CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Mina Sooch, founder and CEO of Ocuphire Pharma, discusses an upcoming new drug application submission for Nyxol eye drops and data for an oral agent for diabetic retinopathy.
“We’re excited that this could lead us into a phase 3 program and towards approval a few years later,” she said.